Gamma announces Astrea, Avacta partnership

By staff writers

December 23, 2020 -- Life sciences firm Gamma Biosciences has announced a licensing agreement between chromatography developer Astrea Bioseparations and biotherapeutic and reagent developer Avacta.

The licensing agreement gives Astrea access to Avacta's Affimer reagent technology for applications in bioprocessing, expanding its range of ligand discovery and development capabilities to include chemical and biological platforms for customer development programs, Gamma said.

Copyright © 2020

To read this and get access to all of the exclusive content on, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?